Aminoglycoside or Polymyxin Monotherapy for Treating Complicated Urinary Tract Infections Caused by Extensively Drug-Resistant Pseudomonas aeruginosa: A Propensity Score-Adjusted and Matched Cohort Study

被引：0
|
作者：
Inmaculada López Montesinos
Silvia Gómez-Zorrilla
Zaira Raquel Palacios-Baena
Nuria Prim
Daniel Echeverria-Esnal
María Pilar Gracia
María Milagro Montero
Xavier Durán-Jordà
Elena Sendra
Luisa Sorli
Roberto Guerri-Fernandez
Eduardo Padilla
Santiago Grau
Juan Pablo Horcajada
机构：
[1] Hospital del Mar,Infectious Diseases Service
[2] Infectious Pathology and Antimicrobials Research Group (IPAR),Unit of Infectious Diseases and Clinical Microbiology. Institute of Biomedicine of Seville (IBIS)
[3] Institut Hospital del Mar d’Investigacions Mèdiques (IMIM),Microbiology Service
[4] Universitat Pompeu Fabra (UPF),Pharmacy Service, Hospital del Mar, Infectious Pathology and Antimicrobials Research Group (IPAR), Institut Hospital del Mar d’Investigacions Mèdiques (IMIM)
[5] Spanish Network for Research in Infectious Diseases (REIPI),Intensive Care Unit Service, Hospital del Mar, Institut Hospital del Mar d’Investigacions Mèdiques (IMIM)
[6] University Hospital Virgen Macarena,Methodology and Biostatistics Support Unit
[7] Laboratori de Referència de Catalunya,undefined
[8] Universitat Pompeu Fabra (UPF),undefined
[9] Universitat Pompeu Fabra (UPF),undefined
[10] Institut Hospital del Mar d’Investigacions Mèdiques (IMIM),undefined
来源：
Infectious Diseases and Therapy | 2022年 / 11卷
关键词：
Extensively drug-resistant ; Urinary tract infections; Amikacin; Colistin; Antimicrobial stewardship;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：335 / 350
页数：15
相关论文
共 33 条
  • [1] Aminoglycoside or Polymyxin Monotherapy for Treating Complicated Urinary Tract Infections Caused by Extensively Drug-Resistant Pseudomonas aeruginosa: A Propensity Score-Adjusted and Matched Cohort Study
    Lopez Montesinos, Inmaculada
    Gomez-Zorrilla, Silvia
    Palacios-Baena, Zaira Raquel
    Prim, Nuria
    Echeverria-Esnal, Daniel
    Gracia, Maria Pilar
    Montero, Maria Milagro
    Duran-Jorda, Xavier
    Sendra, Elena
    Sorli, Luisa
    Guerri-Fernandez, Roberto
    Padilla, Eduardo
    Grau, Santiago
    Horcajada, Juan Pablo
    INFECTIOUS DISEASES AND THERAPY, 2022, 11 (01) : 335 - 350
  • [2] Comparative Analysis of Complicated Urinary Tract Infections Caused by Extensively Drug-Resistant Pseudomonas aeruginosa and Extended-Spectrum β-Lactamase-Producing Klebsiella pneumoniae
    Sendra, Elena
    Lopez Montesinos, Inmaculada
    Rodriguez-Alarcon, Alicia
    Du, Juan
    Siverio-Pares, Ana
    Arenas-Miras, Mar
    Canas-Ruano, Esperanza
    Prim, Nuria
    Duran-Jorda, Xavier
    Blasco-Hernando, Fabiola
    Garcia-Alzorriz, Enric
    Cots, Francesc
    Ferrandez, Olivia
    Gomez-Zorrilla, Silvia
    ANTIBIOTICS-BASEL, 2022, 11 (11):
  • [3] Colistin for the treatment of urinary tract infections caused by extremely drug-resistant Pseudomonas aeruginosa: Dose is critical
    Sorli, Luisa
    Luque, Sonia
    Li, Jian
    Campillo, Nuria
    Danes, Marc
    Montero, Milagro
    Segura, Concha
    Grau, Santiago
    Pablo Horcajada, Juan
    JOURNAL OF INFECTION, 2019, 79 (03) : 253 - 261
  • [4] Successful use of prolonged cefiderocol monotherapy for the treatment of a complex pleural abscess caused by extensively drug-resistant (XDR) Pseudomonas aeruginosa
    Brookfield, Charlotte
    Fadden, Emma
    Sweeney, Louise
    JAC-ANTIMICROBIAL RESISTANCE, 2023, 5 (05):
  • [5] Optimal treatment of ceftazidime-avibactam and aztreonam-avibactam against bloodstream infections or lower respiratory tract infections caused by extensively drug-resistant or pan drug-resistant (XDR/PDR) Pseudomonas aeruginosa
    Kang, Yixin
    Xie, Lu
    Yang, Jiyong
    Cui, Junchang
    FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2023, 13
  • [6] Comparing ceftazidime/avibactam and polymyxin B for treating carbapenem-resistant organisms infections: A propensity score-matched retrospective cohort study
    Liu, Chunmei
    Leng, Bing
    Xie, Maoyu
    Jiang, Shuangyan
    Guan, Xiaoyan
    Xu, Jiahui
    Guo, Yuqing
    Jiang, Jinjiao
    Zeng, Juan
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2025, 65 (03)
  • [7] Risk factors and prognosis of complicated urinary tract infections caused by Pseudomonas aeruginosa in hospitalized patients: a retrospective multicenter cohort study
    Gomila, Aina
    Carratala, J.
    Eliakim-Raz, N.
    Shaw, E.
    Wiegand, I.
    Vallejo-Torres, L.
    Gorostiza, A.
    Vigo, J. M.
    Morris, S.
    Stoddart, M.
    Grier, S.
    Vank, C.
    Cuperus, N.
    Van den Heuvel, L.
    Vuong, C.
    MacGowan, A.
    Leibovici, L.
    Addy, I.
    Pujol, M.
    INFECTION AND DRUG RESISTANCE, 2018, 11 : 2571 - 2581
  • [8] CIPROFLOXACIN THERAPY IN COMPLICATED URINARY-TRACT INFECTIONS CAUSED BY PSEUDOMONAS-AERUGINOSA AND OTHER RESISTANT-BACTERIA
    LEIGH, DA
    EMMANUEL, FXS
    PETCH, VJ
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1986, 18 : 117 - 121
  • [9] Novel β-lactam-β-lactamase inhibitors as monotherapy versus combination for the treatment of drug-resistant Pseudomonas aeruginosa infections: A multicenter cohort study
    Almangour, Thamer A.
    Ghonem, Leen
    Alassiri, Dareen
    Aljurbua, Alanoud
    Al Musawa, Mohammed
    Alharbi, Aminah
    Almuhisen, Sara
    Alghaith, Jeelan
    Damfu, Nader
    Aljefri, Doaa
    Alfahad, Wafa
    Alrasheed, Marwan
    Khormi, Yaqoub
    Almohaizeie, Abdullah
    JOURNAL OF INFECTION AND CHEMOTHERAPY, 2024, 30 (10) : 1008 - 1014
  • [10] Clinical experience with ceftazidime/avibactam in patients with severe infections, including meningitis and lung abscesses, caused by extensively drug-resistant Pseudomonas aeruginosa
    Xipell, Marc
    Bodro, Marta
    Marco, Francesc
    Losno, Ricardo A.
    Cardozo, Celia
    Soriano, Alex
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2017, 49 (02) : 266 - 268
1234